前收市價 | 116.56 |
開市 | 115.73 |
買盤 | 115.58 x 800 |
賣出價 | 117.79 x 1200 |
今日波幅 | 115.73 - 119.89 |
52 週波幅 | 81.14 - 143.68 |
成交量 | |
平均成交量 | 368,174 |
市值 | 2.83B |
Beta 值 (5 年,每月) | 0.68 |
市盈率 (最近 12 個月) | 19.97 |
每股盈利 (最近 12 個月) | 5.88 |
業績公佈日 | 2023年10月04日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 159.60 |
DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on the shares of Beachbody Company Inc (NYSE: BODY). The company issued a press release reaffirming its 4Q22 guidance for revenue of $140 million - $150 million. In the analyst's model, the EBITDA loss in 2022 estimate is narrowed to $(37) million versus $(86) million in 2021. During a chat with the analyst, the CFO did say the company is aiming for positive EBITDA in 2023E. Feedback from the Coaches was that there was too much comp
Helen Of Troy Ltd (NASDAQ: HELE) reported a third-quarter FY23 sales decline of 10.6% year-on-year to $558.6 million, beating the consensus of $552.89 million. Core business net sales decreased 10% Y/Y and 9.6% compared to Q3 FY21. The company attributed the sale decline primarily to a decrease from Organic business of $115.6 million, or 18.5%, reflecting lower consumer demand and shifts in consumer spending patterns. Total net sales revenue for the Home & Outdoor segment fell 7% Y/Y, Health & W
DA Davidson analyst Linda Bolton Weiser upgraded Helen Of Troy (NASDAQ: HELE) from Neutral to Buy and raised the price target from $115 to $126. The analyst said Helen should benefit from the severity of the flu season. As CDC data showed, this flu season has started out to be one of the severest in recent history, said the analyst. Incidence of flu symptoms reported by medical professionals hit a recent peak of 7.5% in the week ended November 27, 2022 and is still very high at 6.9%. Weiser note